$ABBV Headlines Paulson takes stake in Abbvie,
Post# of 72741
Posted On: 11/24/2014 10:37:17 AM
$ABBV Headlines
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Obama considering Lazard banker for Treasury post 4:20 p.m. Nov. 12, 2014 - Victoria McGrane
77 stocks in the S&P 500 Index rise to new highs 10:50 a.m. Nov. 12, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
S&P 500, Dow close at record levels 4:16 p.m. Oct. 31, 2014 - Barbara Kollmeyer
Apple rallies to record high; LinkedIn jumps 11:05 a.m. Oct. 31, 2014 - Sue Chang
AbbVie stock up 3.6% at $63.38 9:32 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie shares up 4% in premarket trade 8:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie raises outlook as profit, sales beat 8:26 a.m. Oct. 31, 2014 - MarketWatch.com
AbbVie shares up 2% as profit, sales beat estimates 8:00 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie prior FY EPS outlook was $3.06 to $3.16 7:54 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie's stock gains 2.2% premarket after Q3 results beat expectations 7:53 a.m. Oct. 31, 2014 - Tomi Kilgore
AbbVie raises FY EPS outlook to $3.25 to $3.27 7:53 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 FactSet revenue consensus $4.831 bln 7:53 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 FactSet EPS consensus 77 cents 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 revenue $5.019 bln, up 7.85 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 adj. EPS 89 cents 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 EPS 31 cents vs 60 cents 7:51 a.m. Oct. 31, 2014 - Ciara Linnane
Mylan 3Q profit soars as revenue tops estimates 5:19 p.m. Oct. 30, 2014 - MarketWatch.com
12 highest-yielding ‘dividend aristocrat’ stocks 10:38 a.m. Oct. 30, 2014 - Philip van Doorn
Today AbbVie (ABBV) Hits New Lifetime High 52 min ago - TheStreet.com
Tracking Dan Loeb's Third Point Portfolio - Q3 2014 Update 2:26 a.m. Today - Seeking Alpha
John Paulson's Top 5 New Holdings For Q3 9:08 p.m. Nov. 21, 2014 - GuruFocus.com
Dividend Aristocrats In Focus Part 41: Abbott Laboratories 9:01 p.m. Nov. 21, 2014 - Seeking Alpha
John Paulson's Top 5 New Holdings for Q3 8:53 p.m. Nov. 21, 2014 - GuruFocus.com
Can New Launches Offset Sanofi's Soft Diabetes Business? - Analyst Blog 5:10 p.m. Nov. 21, 2014 - Zacks.com
Amgen and AbbVie Strengthen Manufacturing Facilities in Asia - Analyst Blog 5:00 p.m. Nov. 21, 2014 - Zacks.com
Alibaba: The Top New Position For Hedge Funds 3:21 p.m. Nov. 21, 2014 - Seeking Alpha
AbbVie, Celgene, Sanofi Drugs Get EU Endorsements 11:28 a.m. Nov. 21, 2014 - Investors Business Daily
European Ad Comm gives thumbs up to AbbVie's HCV combo 8:48 a.m. Nov. 21, 2014 - Seeking Alpha
Tracking David Tepper's Appaloosa Management Portfolio - Q3 2014 Update 8:44 a.m. Nov. 21, 2014 - Seeking Alpha
J&J Seeks FDA Approval for Schizophrenia Treatment - Analyst Blog 4:45 p.m. Nov. 20, 2014 - Zacks.com
Shire to Relocate Employees Under One Shire Program - Analyst Blog 4:35 p.m. Nov. 20, 2014 - Zacks.com
Facebook Among New Holdings in Steve Mandel's Portfolio 4:31 p.m. Nov. 20, 2014 - GuruFocus.com
FDA clears Purdue's abuse-deterrent opioid 1:36 p.m. Nov. 20, 2014 - Seeking Alpha
Independent Thinking For Successful Dividend Investing 9:52 p.m. Nov. 19, 2014 - Seeking Alpha
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog 5:57 p.m. Nov. 19, 2014 - Zacks.com
Why We're Huge Fans Of Gilead 4:33 p.m. Nov. 19, 2014 - Seeking Alpha
AstraZeneca Targets More than $45B in Revenues in 2023 - Analyst Blog 4:20 p.m. Nov. 19, 2014 - Zacks.com
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook 1:00 a.m. Nov. 19, 2014 - Zacks.com
CHMP Grants Positive Opinions of AbbVie's VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe 8:00 a.m. Nov. 21, 2014 - PR Newswire - PRF
AbbVie to Present at Jefferies 2014 Global Healthcare Conference 7:00 a.m. Nov. 17, 2014 - PR Newswire - PRF
AbbVie Presents Results from Study of ABT-414 in Patients with Glioblastoma Multiforme at the 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology 4:48 p.m. Nov. 14, 2014 - PR Newswire - PRF
AbbVie to Present Results from Studies in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) and Liver Transplant Recipients (CORAL-I) at The Liver Meeting® 2014 9:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
AbbVie to Present Results from Phase 2 PEARL-I Study in Genotype 4 Chronic Hepatitis C Patients at The Liver Meeting® 2014 8:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Infinity Reports Third Quarter 2014 Financial Results and Provides Company Update 4:01 p.m. Nov. 6, 2014 - BusinessWire - BZX
Technical Notes Covering Pharma Equities - AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, and Teva Pharma Industries 8:50 a.m. Nov. 6, 2014 - PR Newswire - PRF
ABBVIE (ABBV) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating AbbVie Inc. For Potential Securities Fraud and Breach of Fiduciary Duty 8:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
AbbVie to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
ABBVIE INC. ALERT -- Andrews & Springer LLC is Investigating AbbVie Inc. for Potential Securities Fraud and Breach of Fiduciary Duty 8:09 a.m. Nov. 3, 2014 - GlobeNewswire
Myriad and AbbVie Sign Expanded Agreement for Tumor BRACAnalysis CDx(TM) 7:05 a.m. Nov. 3, 2014 - GlobeNewswire
CMK Select Recognized as Women's Business Enterprise 10:45 a.m. Oct. 31, 2014 - Marketwired
AbbVie Reports Third-Quarter 2014 Financial Results 7:49 a.m. Oct. 31, 2014 - PR Newswire - PRF
If You Purchased Shire plc American Depository Receipts ("ADRs"
During The Period Of June 20, 2014 And October 14, 2014 And Lost Money, Gardy & Notis, LLP Encourages You To Contact The Law Firm 8:38 a.m. Oct. 29, 2014 - PR Newswire - PRF
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly 8:35 a.m. Oct. 29, 2014 - PR Newswire - PRF
AbbVie Named a Top Employer in Science Magazine's Annual Survey for Second Consecutive Year 8:00 a.m. Oct. 23, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
AbbVie Announces New $5 Billion Stock Repurchase Program and Increases Dividend 5:31 p.m. Oct. 20, 2014 - PR Newswire - PRF
Announcement Of Termination Of Proposed AbbVie And Shire Transaction 5:12 p.m. Oct. 20, 2014 - PR Newswire - PRF
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna 8:35 a.m. Oct. 20, 2014 - PR Newswire - PRF
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Obama considering Lazard banker for Treasury post 4:20 p.m. Nov. 12, 2014 - Victoria McGrane
77 stocks in the S&P 500 Index rise to new highs 10:50 a.m. Nov. 12, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
S&P 500, Dow close at record levels 4:16 p.m. Oct. 31, 2014 - Barbara Kollmeyer
Apple rallies to record high; LinkedIn jumps 11:05 a.m. Oct. 31, 2014 - Sue Chang
AbbVie stock up 3.6% at $63.38 9:32 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie shares up 4% in premarket trade 8:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie raises outlook as profit, sales beat 8:26 a.m. Oct. 31, 2014 - MarketWatch.com
AbbVie shares up 2% as profit, sales beat estimates 8:00 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie prior FY EPS outlook was $3.06 to $3.16 7:54 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie's stock gains 2.2% premarket after Q3 results beat expectations 7:53 a.m. Oct. 31, 2014 - Tomi Kilgore
AbbVie raises FY EPS outlook to $3.25 to $3.27 7:53 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 FactSet revenue consensus $4.831 bln 7:53 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 FactSet EPS consensus 77 cents 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 revenue $5.019 bln, up 7.85 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 adj. EPS 89 cents 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 EPS 31 cents vs 60 cents 7:51 a.m. Oct. 31, 2014 - Ciara Linnane
Mylan 3Q profit soars as revenue tops estimates 5:19 p.m. Oct. 30, 2014 - MarketWatch.com
12 highest-yielding ‘dividend aristocrat’ stocks 10:38 a.m. Oct. 30, 2014 - Philip van Doorn
Today AbbVie (ABBV) Hits New Lifetime High 52 min ago - TheStreet.com
Tracking Dan Loeb's Third Point Portfolio - Q3 2014 Update 2:26 a.m. Today - Seeking Alpha
John Paulson's Top 5 New Holdings For Q3 9:08 p.m. Nov. 21, 2014 - GuruFocus.com
Dividend Aristocrats In Focus Part 41: Abbott Laboratories 9:01 p.m. Nov. 21, 2014 - Seeking Alpha
John Paulson's Top 5 New Holdings for Q3 8:53 p.m. Nov. 21, 2014 - GuruFocus.com
Can New Launches Offset Sanofi's Soft Diabetes Business? - Analyst Blog 5:10 p.m. Nov. 21, 2014 - Zacks.com
Amgen and AbbVie Strengthen Manufacturing Facilities in Asia - Analyst Blog 5:00 p.m. Nov. 21, 2014 - Zacks.com
Alibaba: The Top New Position For Hedge Funds 3:21 p.m. Nov. 21, 2014 - Seeking Alpha
AbbVie, Celgene, Sanofi Drugs Get EU Endorsements 11:28 a.m. Nov. 21, 2014 - Investors Business Daily
European Ad Comm gives thumbs up to AbbVie's HCV combo 8:48 a.m. Nov. 21, 2014 - Seeking Alpha
Tracking David Tepper's Appaloosa Management Portfolio - Q3 2014 Update 8:44 a.m. Nov. 21, 2014 - Seeking Alpha
J&J Seeks FDA Approval for Schizophrenia Treatment - Analyst Blog 4:45 p.m. Nov. 20, 2014 - Zacks.com
Shire to Relocate Employees Under One Shire Program - Analyst Blog 4:35 p.m. Nov. 20, 2014 - Zacks.com
Facebook Among New Holdings in Steve Mandel's Portfolio 4:31 p.m. Nov. 20, 2014 - GuruFocus.com
FDA clears Purdue's abuse-deterrent opioid 1:36 p.m. Nov. 20, 2014 - Seeking Alpha
Independent Thinking For Successful Dividend Investing 9:52 p.m. Nov. 19, 2014 - Seeking Alpha
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog 5:57 p.m. Nov. 19, 2014 - Zacks.com
Why We're Huge Fans Of Gilead 4:33 p.m. Nov. 19, 2014 - Seeking Alpha
AstraZeneca Targets More than $45B in Revenues in 2023 - Analyst Blog 4:20 p.m. Nov. 19, 2014 - Zacks.com
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook 1:00 a.m. Nov. 19, 2014 - Zacks.com
CHMP Grants Positive Opinions of AbbVie's VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe 8:00 a.m. Nov. 21, 2014 - PR Newswire - PRF
AbbVie to Present at Jefferies 2014 Global Healthcare Conference 7:00 a.m. Nov. 17, 2014 - PR Newswire - PRF
AbbVie Presents Results from Study of ABT-414 in Patients with Glioblastoma Multiforme at the 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology 4:48 p.m. Nov. 14, 2014 - PR Newswire - PRF
AbbVie to Present Results from Studies in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) and Liver Transplant Recipients (CORAL-I) at The Liver Meeting® 2014 9:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
AbbVie to Present Results from Phase 2 PEARL-I Study in Genotype 4 Chronic Hepatitis C Patients at The Liver Meeting® 2014 8:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Infinity Reports Third Quarter 2014 Financial Results and Provides Company Update 4:01 p.m. Nov. 6, 2014 - BusinessWire - BZX
Technical Notes Covering Pharma Equities - AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, and Teva Pharma Industries 8:50 a.m. Nov. 6, 2014 - PR Newswire - PRF
ABBVIE (ABBV) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating AbbVie Inc. For Potential Securities Fraud and Breach of Fiduciary Duty 8:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
AbbVie to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
ABBVIE INC. ALERT -- Andrews & Springer LLC is Investigating AbbVie Inc. for Potential Securities Fraud and Breach of Fiduciary Duty 8:09 a.m. Nov. 3, 2014 - GlobeNewswire
Myriad and AbbVie Sign Expanded Agreement for Tumor BRACAnalysis CDx(TM) 7:05 a.m. Nov. 3, 2014 - GlobeNewswire
CMK Select Recognized as Women's Business Enterprise 10:45 a.m. Oct. 31, 2014 - Marketwired
AbbVie Reports Third-Quarter 2014 Financial Results 7:49 a.m. Oct. 31, 2014 - PR Newswire - PRF
If You Purchased Shire plc American Depository Receipts ("ADRs"
During The Period Of June 20, 2014 And October 14, 2014 And Lost Money, Gardy & Notis, LLP Encourages You To Contact The Law Firm 8:38 a.m. Oct. 29, 2014 - PR Newswire - PRF Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly 8:35 a.m. Oct. 29, 2014 - PR Newswire - PRF
AbbVie Named a Top Employer in Science Magazine's Annual Survey for Second Consecutive Year 8:00 a.m. Oct. 23, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
AbbVie Announces New $5 Billion Stock Repurchase Program and Increases Dividend 5:31 p.m. Oct. 20, 2014 - PR Newswire - PRF
Announcement Of Termination Of Proposed AbbVie And Shire Transaction 5:12 p.m. Oct. 20, 2014 - PR Newswire - PRF
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna 8:35 a.m. Oct. 20, 2014 - PR Newswire - PRF
(0)
(0)